Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAVmed Inc PAVMZ


Primary Symbol: PAVM

Healthcare Medical Devices
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device... see more

Recent & Breaking News (NDAQ:PAVM)

PAVmed to Participate in September Investor and MedTech Conferences

Business Wire September 7, 2021

PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results

Business Wire August 12, 2021

PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers

Business Wire August 10, 2021

PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference

Business Wire August 5, 2021

Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics' Board of Directors

Business Wire August 3, 2021

PAVmed to Hold Business Update Conference Call on August 12, 2021

Business Wire August 2, 2021

Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors

Business Wire July 28, 2021

PAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScriptHealth

Business Wire July 22, 2021

Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors

GlobeNewswire June 14, 2021

PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test

GlobeNewswire June 10, 2021

PAVmed Launches Digital Health Company Veris Health Inc.

GlobeNewswire June 2, 2021

PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device

GlobeNewswire May 26, 2021

PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device

GlobeNewswire May 25, 2021

Data Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics' EsoCheck and EsoGuard Technologies

GlobeNewswire May 24, 2021

PAVmed Provides Business Update and First Quarter 2021 Financial Results

GlobeNewswire May 17, 2021

PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021

GlobeNewswire May 13, 2021

PAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team

GlobeNewswire May 6, 2021

PAVmed to Hold Business Update Conference Call on May 17, 2021

GlobeNewswire May 3, 2021

Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics' Board of Directors

GlobeNewswire April 29, 2021

Global Industry Executive Debbie White Joins PAVmed Board of Directors

GlobeNewswire April 27, 2021